CD8A and neoplasm: In summary, tumor-associated antigens (TAAs) released from apoptotic or necrotic tumor cells are recognized, phagocytized, and processed by DCs in immunogenic peptides that are loaded onto major histocompatibility complex (MHC) class I or class II molecules for presentation to CD8 T cells and CD4 T cells, respectively.